<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF STUDY: This study was conducted to study the clinical and laboratory parameters in patients with <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> and to determine the etiology of <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> with special reference to <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: This study was a cross-sectional descriptive study carried over a period of 18 months on 60 adult patients (age â‰¥13 years) of <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001972'>Macrocytic anemia</z:hpo> was identified when peripheral blood examination showed <z:hpo ids='HP_0001903'>anemia</z:hpo> with a mean red blood corpuscular volume of &gt;95 fl </plain></SENT>
<SENT sid="3" pm="."><plain>RESULT: The most common cause of <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> was <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> (38.4%) </plain></SENT>
<SENT sid="4" pm="."><plain>The major causes of nonmegaloblastic <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> were primary <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorders</z:e> (35%), <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver diseases</z:e> (15%) and <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> (8.3%) </plain></SENT>
<SENT sid="5" pm="."><plain>There was a significant male preponderance in the study (65%) </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:hpo ids='HP_0001889'>megaloblastic anemias</z:hpo> observed were due to either vitamin B(12) deficiency (78.3%) or combined B(12) and <z:chebi fb="3" ids="37445">folate</z:chebi> deficiency (21.7%) </plain></SENT>
<SENT sid="7" pm="."><plain>A significant proportion of non-vegetarians (73.9%) had <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with an MCV of &gt;110fl were more likely to have <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> (p value 0.0007) </plain></SENT>
<SENT sid="9" pm="."><plain>Three patients (mean age 55 years) with a <z:e sem="disease" ids="C0002888" disease_type="Disease or Syndrome" abbrv="">megaloblastic</z:e> marrow did not respond to vitamin replacement and were found to have <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0001889'>Megaloblastic anemia</z:hpo> due to Vitamin B(12) or <z:chebi fb="3" ids="37445">folate</z:chebi> deficiency remains the most important cause of <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>In settings with limited laboratory facilities, a therapeutic trial of vitamins B(12) or <z:chebi fb="9" ids="27470">folic acid</z:chebi> is useful in determining the specific <z:e sem="disease" ids="C1510471" disease_type="Disease or Syndrome" abbrv="">vitamin deficiency</z:e> </plain></SENT>
</text></document>